SCHEMBL21889523

SCHEMBL21889523

C[Si](C)(C)CCOCn1nc(C2CCOCC2)nc1-c1ccc(O)cc1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGAT1 O75907 3/20 0.35
USP7 Q93009 2/20 0.34
BRD4 O60885 3/20 0.33
PDK1 Q15118 1/20 0.33
PDK2 Q15119 1/20 0.33
PDK3 Q15120 1/20 0.33
PDK4 Q16654 1/20 0.33
HTR6 P50406 1/20 0.33
AOC3 Q16853 5/20 0.33
KLKB1 P03952 1/20 0.32
TAF1 P21675 1/20 0.32
BRD2 P25440 1/20 0.32
BRPF1 P55201 1/20 0.32
EP300 Q09472 1/20 0.32
BRD3 Q15059 1/20 0.32
BRDT Q58F21 1/20 0.32
CREBBP Q92793 1/20 0.32
CECR2 Q9BXF3 1/20 0.32
BRD9 Q9H8M2 1/20 0.32
BAZ2B Q9UIF8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21889200 0.93 AOC3 (0.37) DGAT1USP7AOC3KLKB1MAOA
SCHEMBL21889297 0.91 DGAT1 (0.36) DGAT1USP7AOC3KLKB1MAOA
SCHEMBL21914802 0.91 DGAT1 (0.36) DGAT1USP7AOC3KLKB1MAOA
SCHEMBL21889841 0.89 DGAT1 (0.34) DGAT1USP7AOC3KLKB1MAOA
SCHEMBL21889556 0.80 DGAT1 (0.33) DGAT1KLKB1MAOAMAOB
SCHEMBL21889220 0.78 DGAT1 (0.41) DGAT1USP7AOC3KLKB1
SCHEMBL21889199 0.77 DGAT1 (0.45) DGAT1AOC3MAOB
SCHEMBL21889534 0.76 DGAT1 (0.35) DGAT1USP7HTR6KLKB1
SCHEMBL21914812 0.76 AOC3 (0.35) DGAT1AOC3
SCHEMBL21889821 0.76 DGAT1 (0.44) DGAT1MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3626699-B1 SSAO INHIBITOR SHANDONG DANHONG PHARMACEUTICAL CO LTD (CN) 2023-07-12 EP disclosed
US-20210198220-A1 SSAO INHIBITOR SHANDONG DANHONG PHARMACEUTICAL CO LTD (CN) 2021-07-01 US disclosed
US-11001563-B2 SSAO inhibitor SHANDONG DANHONG PHARMACEUTICAL CO LTD (CN) 2021-05-11 US disclosed
US-20200115352-A1 SSAO INHIBITOR SHANDONG DANHONG PHARMACEUTICAL CO., LTD. 2020-04-16 US disclosed
EP-3626699-A1 SSAO INHIBITOR Shandong Danhong Pharmaceutical Co., Ltd. (CN) 2020-03-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11001563-B2 SSAO inhibitor SSB, ASAH2, AOX1 DGAT1 3115/4885USP7 4507/4885BRD4 4029/4885
US-20210198220-A1 SSAO INHIBITOR SSB, ASAH2, AOX1 DGAT1 3115/4885USP7 4507/4885BRD4 4029/4885
US-20200115352-A1 SSAO INHIBITOR SSB, ASAH2, AOX1 DGAT1 3115/4885USP7 4507/4885BRD4 4029/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.